ArticleBMC pediatrics2025
Treatment outcomes and associated factors among children with epilepsy attending the pediatric follow-up clinic at Hiwot Fana Comprehensive Specialized Hospital.
Article in BMC pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundEpilepsy is a common neurological disorder that significantly impacts children's development, behavior, and quality of life. In low-resource settings, treatment outcomes remain suboptimal, with more than one-third of children experiencing treatment failure.
objectivesThis study assessed treatment outcomes and associated factors among children with epilepsy attending the pediatric follow-up clinic at Hiwot Fana Comprehensive Specialized Hospital in Eastern Ethiopia. METHODOLOGY: A hospital-based cross-sectional study was conducted from November 5, 2020, to February 5, 2021, involving 140 children aged 6 months to 18 years who had been on antiepileptic drugs for at least six months. Data was collected through structured caregiver interviews and medical record reviews. Seizure control was categorized as good (seizure-free for at least six months) or poor (persistent seizures despite appropriate AED use). Adherence was measured using the Morisky 8-Item Medication Adherence Scale. Multivariable logistic regression was used to identify factors associated with treatment outcomes.
resultAmong the 140 participants, 59.3% had poor seizure control. Generalized seizures were the most common type (65.7%), and 78.6% were on monotherapy, with phenytoin being the most prescribed AED. Poor adherence to AEDs was observed in 46.4% of patients. In the adjusted analysis, seizure frequency greater than one per week before AED initiation (AOR = 11.036; 95% CI: 3.616-33.677; p < 0.001) and poor adherence to AEDs (AOR = 4.917; 95% CI: 2.452-9.861; p < 0.001) were significantly associated with poor treatment outcomes.
conclusionNearly six in ten children had poor seizure control. High pre-treatment seizure frequency and poor adherence to medication were the main factors associated with poor outcomes. Interventions to promote early diagnosis and improve adherence through caregiver education and health system support are critical to improving epilepsy management in children.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.